IM Cannabis Corp. current report, Q2 FY2022

IM Cannabis Corp. Form 6-K Summary

Business context and reporting period

IM Cannabis Corp., an Israeli foreign private issuer, filed this Form 6-K for May 2022. The filing was signed and dated May 20, 2022, by Oren Shuster, Chief Executive Officer and Director.

Financial metrics

The filing text provided does not contain revenue, profit, cash flow, margin, debt, liquidity, or other operating and financial metrics.

Material changes versus prior period

No period-over-period financial or operating changes are disclosed in the filing text provided.

Guidance, outlook, risks, and unusual items

The filing furnishes Exhibit 99.1, titled “Statement of Executive Compensation” dated May 20, 2022. The contents of that exhibit are not included in the provided filing text, so compensation amounts, arrangements, changes, and related-party information cannot be assessed.

Exhibit 99.1 is incorporated by reference into the Company’s Form F-10 registration statement, File No. 333-254255, as amended or supplemented.

Investor verification items

  • Review Exhibit 99.1 for executive compensation amounts, incentive arrangements, equity awards, and changes from prior periods.
  • Verify whether the incorporated Form F-10 contains additional disclosure relevant to the compensation statement.
  • Do not infer financial performance or liquidity conclusions from this filing, because those metrics are not provided.